Growth Metrics

Gyre Therapeutics (GYRE) Property, Plant & Equipment (Net) (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.11%
Dec 31, 2025 -0.04%
Sep 30, 2025 0.88%
Jun 30, 2025 -0.50%
Mar 31, 2025 -1.52%
Dec 31, 2024 -2.30%
Sep 30, 2024 3.25%
Jun 30, 2024 0.46%
Mar 31, 2024 1.19%
Mar 31, 2023 -99.99%
Dec 31, 2022 14,181.45%
Sep 30, 2022 -24.39%
Jun 30, 2022 -80.86%
Mar 31, 2022 -11.65%
Dec 31, 2021 -11.09%
Sep 30, 2021 59.50%
Jun 30, 2021 79.06%
Mar 31, 2021 -11.78%
Dec 31, 2020 -1.37%
Sep 30, 2020 -8.73%
Jun 30, 2020 62.50%
Mar 31, 2020 -2.63%
Dec 31, 2019 -10.32%
Sep 30, 2019 -8.63%
Jun 30, 2019 4.21%
Mar 31, 2019 -7.77%
Dec 31, 2018 51.37%
Sep 30, 2018 -12.37%
Jun 30, 2018 -10.46%
Mar 31, 2018 17.75%
Dec 31, 2017 -12.38%
Sep 30, 2017 -12.01%
Jun 30, 2017 -10.28%
Mar 31, 2017 -10.14%
Dec 31, 2016 -37.99%
Sep 30, 2016 -10.83%
Jun 30, 2016 17.74%
Mar 31, 2016 -2.29%
Dec 31, 2015 -1.55%
Sep 30, 2015 375.84%
Jun 30, 2015 -60.05%
Mar 31, 2015 -59.06%
Dec 31, 2014 88.61%
Sep 30, 2014 -10.72%
Jun 30, 2014 -11.46%
Mar 31, 2014 -10.41%
Dec 31, 2013 -8.82%
Sep 30, 2013 -20.76%
Jun 30, 2013 -37.11%
Mar 31, 2013 -8.42%